Literature DB >> 19137245

[Anticoagulation in atrial fibrillation - an update].

Matthias Antz1, Bettina Hullmann, Christian Neufert, Wolfgang Vocke.   

Abstract

The correct anticoagulation regimen for prevention of thromboembolic events is essential in patients with atrial fibrillation. However, only a minority of patients receives anticoagulation according to the guidelines. The current guidelines are intended to make the indication for anticoagulation more simple and are summarized in the present article. This includes recommendations for chronic anticoagulation, prevention of thromboembolic events after cardioversion and in ablation of atrial fibrillation.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19137245     DOI： 10.1007/s00059-008-3179-0

Source DB:  PubMed          Journal:  Herz        ISSN： 0340-9937            Impact factor:   1.443


  10 in total

1.  ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Jonathan L Halperin; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  Circulation       Date:  2006-08-15       Impact factor: 29.690

Review 2.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation.

Authors:  Hugh Calkins; Josep Brugada; Douglas L Packer; Riccardo Cappato; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; David E Haines; Michel Haissaguerre; Yoshito Iesaka; Warren Jackman; Pierre Jais; Hans Kottkamp; Karl Heinz Kuck; Bruce D Lindsay; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Andrea Natale; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Jeremy N Ruskin; Richard J Shemin
Journal:  Heart Rhythm       Date:  2007-04-30       Impact factor: 6.343

3.  Venice Chart international consensus document on atrial fibrillation ablation.

Authors:  Andrea Natale; Antonio Raviele; Thomas Arentz; Hugh Calkins; Shih-Ann Chen; Michel Haïssaguerre; Gerhard Hindricks; Yen Ho; Karl Heinz Kuck; Francis Marchlinski; Carlo Napolitano; Douglas Packer; Carlo Pappone; Eric N Prystowsky; Richard Schilling; Dipen Shah; Sakis Themistoclakis; Atul Verma
Journal:  J Cardiovasc Electrophysiol       Date:  2007-05

4.  2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee.

Authors:  Spencer B King; Sidney C Smith; John W Hirshfeld; Alice K Jacobs; Douglass A Morrison; David O Williams; Ted E Feldman; Morton J Kern; William W O'Neill; Hartzell V Schaff; Patrick L Whitlow; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2007-12-13       Impact factor: 29.690

5.  Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Authors:  R G Hart; O Benavente; R McBride; L A Pearce
Journal:  Ann Intern Med       Date:  1999-10-05       Impact factor: 25.391

6.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial.

Authors:  S Connolly; J Pogue; R Hart; M Pfeffer; S Hohnloser; S Chrolavicius; M Pfeffer; S Hohnloser; S Yusuf
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

7.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

8.  Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter.

Authors:  A Z Arnold; M J Mick; R P Mazurek; F D Loop; R G Trohman
Journal:  J Am Coll Cardiol       Date:  1992-03-15       Impact factor: 24.094

9.  Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.

Authors:  Christoph Stellbrink; Uwe Nixdorff; Thomas Hofmann; Walter Lehmacher; Werner Günther Daniel; Peter Hanrath; Christoph Geller; Andreas Mügge; Walter Sehnert; Caroline Schmidt-Lucke; Jan-André Schmidt-Lucke
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

10.  Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation.

Authors:  D Roy; E Marchand; P Gagné; M Chabot; R Cartier
Journal:  Am Heart J       Date:  1986-11       Impact factor: 4.749
  10 in total
  1 in total

1.  [Atrial fibrillation -- a rhythmic problem with growing significance].

Authors:  Erik Wissner; Julian K R Chun; Karl-Heinz Kuck
Journal:  Herz       Date:  2008-12       Impact factor: 1.443
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.